Stock comparison
IDEXX LABORATORIES INC /DE is 29.4x more valuable than Anbio Biotechnology by market capitalization ($44.06 B vs $1.50 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
IDXX is larger
IDEXX LABORATORIES INC /DE is 29.4x more valuable than Anbio Biotechnology by market capitalization ($44.06 B vs $1.50 B).
Market value leader
IDXX
IDEXX LABORATORIES INC /DE is 29.4x more valuable than Anbio Biotechnology by market capitalization ($44.06 B vs $1.50 B).
Revenue leader
IDXX
IDXX: $4.30B vs NNNN: $8.65M.
Profit leader
IDXX
IDXX: $1.06B vs NNNN: $6.40M.
Margin leader
NNNN
IDXX: 24.6% vs NNNN: 74.1% net margin.
| Metric | IDXX | NNNN |
|---|---|---|
| Market cap | $44.06 B | $1.50 B |
| US-listed rank | #358 | #2355 |
| Revenue (latest FY) | $4.30B | $8.65M |
| Net income (latest FY) | $1.06B | $6.40M |
| Net margin | 24.6% | 74.1% |
| P/E (trailing FY) | 41.6x | 234.2x |
| SEC filings | 2,148 | 40 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
IDEXX LABORATORIES INC /DE is 29.4x more valuable than Anbio Biotechnology by market capitalization ($44.06 B vs $1.50 B).
In their latest fiscal years, IDEXX LABORATORIES INC /DE reported $4.30B in revenue while Anbio Biotechnology reported $8.65M.
Full pages: IDEXX LABORATORIES INC /DE and Anbio Biotechnology, or browse the full rankings.